The agenda, keynote presentations, and more are announced for this year’s CONVERGENCE ’24 conference.
In a recent press release, the Council for Responsible Nutrition (CRN; Washington, D.C.) announced the opening keynote speaker for its CONVERGENCE ’24 conference, taking place October 9–11, 2024, in Salt Lake City, Utah, at the Grand America Hotel. On October 10, the Food and Drug Administration’s (FDA) Deputy Commissioner for Human Foods, Jim Jones will be presenting on dietary supplement oversight and the agency’s new framework, enforcement priorities, and possible legislative updates to the Dietary Supplement Health and Education Act (DSHEA) the agency would support.
Also presenting at CONVERGENCE ’24 are Noelle Russell, Founder and Chief AI Officer of AI Leadership Institute and Chris Cillizza, former CNN Politics reporter.
“CRN’s carefully curated program of keynote speakers for CONVERGENCE ‘24 is designed to help keep supplement industry stakeholders connected to the latest developments at FDA, inspire innovation sparked by discussions around the future of AI, and make sense of what today’s headlines portend for the global political landscape,” stated CRN President and CEO Steve Mister, in the press release. “And, of course, attendees will enjoy the ample opportunities for networking and conversation about what’s next for our industry as we celebrate the 30th anniversary of DSHEA.”
Prior to the keynote presentations, several other events will take place on October 9, including the first Innovation Exchange, six 25-minute presentations on ingredient research and innovation, manufacturing, and more.
Additionally, the WellComms forum, an event for marketing and communications professionals, will feature presentations on the latest trends and strategies in the supplement industry based on new consumer behaviors.
Finally, the theme for this year’s Science in Session is “Living Well Longer: Bioactive Innovations for Healthy Aging,” and will cover topics such as research on bioactives for healthy longevity, cognition, bone and skin health, inflammation and obesity, and others.
The agenda includes the following presentations:
Registration for these events is open to both members and non-members and can be found at www.crnusa.org/2024events.
Gencor to distribute Gnosis by Lesaffre’s Landkind Pure Salidroside in the United States
September 11th 2024The ingredient is manufactured by Gnosis by Lesaffre as an alternative to rhodiola extract. Salidroside is the most studied bioactive in rhodiola, to which the extract efficacy is attributed to.
New review from BAPP estimates adulteration of five popular botanicals
September 10th 2024The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.